NucliRay Defence IVS: Financial statements 2016
CVR: 37175439
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
NucliRay Defence IVS (CVR 37175439) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -65,916 and a net result of DKK -132,703. Equity in the 2016 report amounted to DKK 70,626. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -65,916
- Profit/Loss
- DKK -132,703
- Equity
- DKK 70,626
- Total Assets
- DKK 70,626
Official annual report
Find more companies like NucliRay Defence IVS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of October 1, 2016, Mathias Spliid Heltberg is registered as director of NucliRay Defence IVS.
NucliRay Defence IVS has published its interim report for the period October 23, 2015 to December 31, 2015.
As of May 25, 2016, Ahmad Zakria Gardizi has stepped down as director of NucliRay Defence IVS.
About NucliRay Defence IVS
NucliRay Defence IVS was a Danish company of the type Iværksætterselskab based in København K, founded in 2015. The company has been dissolved on 6 May 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2020, the company reported a net result of DKK 0 compared with DKK -1,896 the year before. Equity in the 2020 report amounted to DKK 68,133.